Skip to content

Life Sciences

Our Global Life Sciences sector can help you navigate forward and achieve sustainable success in the new health-outcomes-driven ecosystem.

Aging populations and chronic disease are putting pressure on health resources around the world just as scientific progress, augmented intelligence and digital data are transforming the traditional health care models. This is causing a power shift with new entrants (often not driven by profit) disrupting the incumbents.

Staying competitive and providing the personalized experience that patients demand require life sciences organizations to find new ways of working. Partnering with others to share data, medicine and resources while anticipating trends and regulatory changes will help ensure sustainability in the increasingly evidence-based, outcomes-focused sector.

We help companies across the biotechnology, pharmaceutical and medical technology fields harness this disruption by forming the right alliances, better allocating resources and building trust with customers.

Featured Thinking

close up shot of two children playing chess together

Our Latest thinking

The Unstoppables: Success stories of the world’s most inspiring entrepreneurs

The latest EY entrepreneurship documentary, “The Unstoppables 3,” features inspiring professional and personal entrepreneur success stories. Read more.

09 Apr 2024 Stasia Mitchell

Pulse of the MedTech Industry report 2024

2024 EY MedTech report on dealmaking, financing, and state of the industry, with insights on growth and commercial strategies, AI, consumer and more.

07 Oct 2024 Jim Welch + 2

Beyond Borders: EY Biotechnology Report 2024

New EY biotechnology report with deal, financing and other data, plus insights on AI, GLP-1 drugs, oncology breakthroughs, the VC lens and much more.

03 Jun 2024

How will you respond to clinicians sounding the alarm on unsustainable care delivery models?

The EY Global Voices in Health Care Study finds health systems must embrace sustainable care delivery models to address workforce challenges. Learn more.

16 Oct 2023

How life sciences businesses transform the tax and finance function

Life sciences organizations operate in a complex industry – one that looks set to become more challenging, including from a tax perspective. Learn more.

07 Mar 2023 EY Global

How CDMOs are leading innovation for pharmaceutical partners

Discover how CDMO M&A trends show CDMOs are becoming emerging technology leaders for pharmaceutical partners.

14 Jul 2022

What going digital means for Takeda

Find out how Takeda Business Solutions (TBS) fast-tracked its digitalization evolution.

01 Jul 2022 Helmut Rattenberger + 1

How to navigate global TP controversy in life sciences — Asia-Pacific and Europe focus

In this webcast, panelists discuss life sciences transfer pricing controversy trends and developments in Asia-Pacific and Europe. Learn more.

23 Jun 2022 | your local time

How to navigate global TP controversy in life sciences — US focus

In this webcast, panelists discuss life sciences transfer pricing controversy trends and developments in the US. Learn more.

22 Jun 2022 | your local time

 How the future of health care is becoming a reality

Human-centric care will soon become a reality, driven by data and technology.

22 Jun 2021 Pamela Spence

    Life Sciences 4.0

    When the human body is the biggest data platform, who will capture value?

    Learn more

    How EY can help

    Linda Hill

    EY Global and Americas Consumer and Health Leader
    Strategic leader focused on innovation. Collaborative team builder. Champion for audit quality. Client-centric problem solver. Avid reader. Ambitious hiker. Occasional middle school sports coach.
    St. Louis, USA

    Daniel Mathews

    EY Global Life Sciences Leader; EY EMEIA Life Sciences Market Lead
    Passionate about driving health outcomes. Focused on making pharmaceutical innovations affordable and easily accessible to everyone.
    London, GBR
    Contact us
    Like what you’ve seen? Get in touch to learn more.

    EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.